Xylocor Therapeutics

Developer of gene therapies for the treatment of coronary arterial disease

placeNewtown Square, Pennsylvania, United States calendar_todayFounded 2013 groups18 employees language xylocor.com

Innovation

1 patent family — focus: Human necessities; filing pace slowing. Cited 16 times.

YearFilings
20211
20221
20231
20241

Social engagement

Social engagement: 2.3K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Fountain Healthcare Partners, Sofinnova Investments, Life Sciences Partners, Jeito.

Investor typeCountShare
Venture capital571%
Private equity229%

Recent activity

5 Mar 2026
Leadership hire
President and Chief Executive Officer
21 Oct 2025
Event
2025 Longwood Healthcare Leaders Boston CEO event
10 Jul 2025
Milestone
regulatory
Coming soon